Nasopharyngeal Carcinoma Risk Stratification: Current Evidence and Emerging Approaches
Current Oncology · 03.11.2026 · 33 (11) · 671
DOI: 10.3390/curroncol33110671 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, online erschienen am 03.11.2026. Verfasst von Maria Alina Marin und 6 weiteren Autor:innen. Die Arbeit nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Nasopharyngeal carcinoma is characterized by marked biological and clinical heterogeneity that is only partly captured by conventional anatomical staging. This narrative review examines how circulating biomarkers, radiomics, artificial intelligence (AI), molecular profiling, and functional tumor models may complement tumor-node-metastasis (TNM)-based risk stratification in nasopharyngeal carcinoma (NPC). Relevant literature was identified through searches of PubMed, ScienceDirect, and Google Scholar, primarily covering 2016–2026, with earlier landmark studies retained when relevant. Plasma Epstein–Barr virus (EBV) DNA is an established prognostic biomarker that complements anatomical staging, while longitudinal measurements provide information on treatment response and recurrence risk. Radiomics and AI offer additional possibilities for prognostic modeling, although their use in treatment selection remains investigational. Genomic, epigenomic, transcriptomic, single-cell, spatial, proteomic, and phosphoproteomic studies characterize tumor and microenvironmental heterogeneity. Organoids, xenografts, humanized models, and engineered three-dimensional systems provide complementary platforms for functional investigation.
Zitieren
APA
Marin, M. A., Sarău, O. S., Ardelean, A., Horhat, D. I., Sarău, C. A., Liga, S., & Balica, N. C. (2026). Nasopharyngeal Carcinoma Risk Stratification: Current Evidence and Emerging Approaches. Current Oncology, 33(11), 671. https://doi.org/10.3390/curroncol33110671
Vancouver
Marin MA, Sarău OS, Ardelean A, Horhat DI, Sarău CA, Liga S, et al. Nasopharyngeal Carcinoma Risk Stratification: Current Evidence and Emerging Approaches. Current Oncology. 2026;33(11):671. doi:10.3390/curroncol33110671
BibTeX
@article{Marin2026,
author = {Marin, Maria Alina and Sarău, Oana Silvana and Ardelean, Andra and Horhat, Delia Ioana and Sarău, Cristian Andrei and Liga, Sergio and Balica, Nicolae Constantin},
title = {Nasopharyngeal Carcinoma Risk Stratification: Current Evidence and Emerging Approaches},
journal = {Current Oncology},
year = {2026},
volume = {33},
number = {11},
pages = {671},
doi = {10.3390/curroncol33110671}
}
EUVIMED